Abbott (NYSE: ABT) and BG Medicine, Inc. announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott’s ARCHITECT immunochemistry instrument platform, specifically the company’s i1000SR and i2000SR instruments. The agreement grants Abbott a [...]

Antigenics Inc. (NASDAQ: AGEN) announced that GlaxoSmithKline (GSK) has launched a Phase 3 study with the world’s most clinically-advanced malaria vaccine, RTS,S, which contains Antigenics’ QS-21 Stimulon® adjuvant.

The age-old question of whether pride is the seventh sin or an adaptive virtue has been answered by two Northeastern University scientists.
Contrary to popular belief, the researchers found that pride not only leads individuals to take on leadership roles in teams, but also fosters admiration, as opposed to scorn, from teammates.

Astrophysicists peer into the far corners of deep space for dark matter, but for neuroscientists at the Queensland Brain Institute (QBI) exploring the unknown is much closer to home.